If you were to ask a group of people why brain cancer would rise to the surface, the various answers given will show that there is no concrete reasoning. Enzymes could play a role in the matter, as it's been said that they can trigger and make this condition progress. This is especially true when focusing on glioblastoma, the most common and aggressive type of cancer in this regard. Focusing on enzymes, though, what can be done in order to stop them in their tracks?
Futurity posted an article that went into detail about a method that could come into play. It was described as a "backdoor" approach that would be followed through with in order to help brain cancer. The ability to halt an enzyme related to glioblastoma is one that deserves to be considered, as organizations such as Voices against Brain Cancer would be able to tell you. The details on the matter may not be made clear, though, so what exactly do these include, one has to wonder?
The enzyme in particular that was looked at was given the name of phospholipase D, though it isn't relevant to brain cancer alone. In fact, it is one that has been focused on while focusing on cancers the likes of breast and gastric. It's apparent that PLD has been given a tremendous amount of focus but another point to take into account is how it was able to regulate Akt. For those who are unaware, Akt is an enzyme that also plays into the growth of cancer.
PLD was given a tremendous amount of focus during a study with mice, each of the subjects afflicted with glioblastoma. One would assume that simply locking Akt would aid the problem but, as the article detailed, it is a course of action that stands a great chance of creating strong actions in the body. An exaggerated immune response, for example, could come to the surface. This subject deserves focus, without question, but care is another element that shouldn't be ignored.
Professor Craig Lindsley spoke about the concept of the isoform related to Akt being targeted without bringing any kind of harm to the patient. Keep in mind that if Akt is not activated, the cancerous cells in the body die out, which is especially worthy of note when considering that the patient is not harmed as a result. Safety should be top priority when talking about any field of research. The focus given on certain enzymes, in my opinion, is one that can open up greater possibilities.
Futurity posted an article that went into detail about a method that could come into play. It was described as a "backdoor" approach that would be followed through with in order to help brain cancer. The ability to halt an enzyme related to glioblastoma is one that deserves to be considered, as organizations such as Voices against Brain Cancer would be able to tell you. The details on the matter may not be made clear, though, so what exactly do these include, one has to wonder?
The enzyme in particular that was looked at was given the name of phospholipase D, though it isn't relevant to brain cancer alone. In fact, it is one that has been focused on while focusing on cancers the likes of breast and gastric. It's apparent that PLD has been given a tremendous amount of focus but another point to take into account is how it was able to regulate Akt. For those who are unaware, Akt is an enzyme that also plays into the growth of cancer.
PLD was given a tremendous amount of focus during a study with mice, each of the subjects afflicted with glioblastoma. One would assume that simply locking Akt would aid the problem but, as the article detailed, it is a course of action that stands a great chance of creating strong actions in the body. An exaggerated immune response, for example, could come to the surface. This subject deserves focus, without question, but care is another element that shouldn't be ignored.
Professor Craig Lindsley spoke about the concept of the isoform related to Akt being targeted without bringing any kind of harm to the patient. Keep in mind that if Akt is not activated, the cancerous cells in the body die out, which is especially worthy of note when considering that the patient is not harmed as a result. Safety should be top priority when talking about any field of research. The focus given on certain enzymes, in my opinion, is one that can open up greater possibilities.
About the Author:
If you'd care to learn more about feats to raise awareness for brain cancer, please visit Voices against Brain Cancer.
No comments:
Post a Comment